Dr. Falk Pharma

About

Dr. Falk Pharma GmbH is a family‑owned pharmaceutical company with over six decades of experience developing and marketing innovative medicines for gastrointestinal and hepatobiliary disorders, including inflammatory bowel disease, eosinophilic esophagitis, and primary biliary cholangitis. The company combines clinical expertise, scientific research, and patient input to design therapies that improve therapeutic practice and patient well‑being, operating from pre‑clinical to clinical stages. With headquarters and R&D in Freiburg, Germany, and manufacturing sites across Europe, Dr. Falk Pharma serves a global market through ten affiliates in Europe and Australia. Its distinctive strength lies in a collaborative, patient‑centric approach that integrates physicians, scientists, and patients to advance digestive and metabolic medicine. Employing roughly 1,400 professionals worldwide, the firm remains committed to advancing high‑quality, evidence‑based treatments.